Cargando…

Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample

INTRODUCTION: Although neuroscience has made tremendous progress towards understanding the basic neural circuitry underlying important processes such as attention, memory and emotion, little progress has been made in applying these insights to psychiatric populations to make clinically meaningful tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Victor, Teresa A, Khalsa, Sahib S, Simmons, W Kyle, Feinstein, Justin S, Savitz, Jonathan, Aupperle, Robin L, Yeh, Hung-Wen, Bodurka, Jerzy, Paulus, Martin P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786129/
https://www.ncbi.nlm.nih.gov/pubmed/29371263
http://dx.doi.org/10.1136/bmjopen-2017-016620
_version_ 1783295742172987392
author Victor, Teresa A
Khalsa, Sahib S
Simmons, W Kyle
Feinstein, Justin S
Savitz, Jonathan
Aupperle, Robin L
Yeh, Hung-Wen
Bodurka, Jerzy
Paulus, Martin P
author_facet Victor, Teresa A
Khalsa, Sahib S
Simmons, W Kyle
Feinstein, Justin S
Savitz, Jonathan
Aupperle, Robin L
Yeh, Hung-Wen
Bodurka, Jerzy
Paulus, Martin P
author_sort Victor, Teresa A
collection PubMed
description INTRODUCTION: Although neuroscience has made tremendous progress towards understanding the basic neural circuitry underlying important processes such as attention, memory and emotion, little progress has been made in applying these insights to psychiatric populations to make clinically meaningful treatment predictions. The overall aim of the Tulsa 1000 (T-1000) study is to use the NIMH Research Domain Criteria framework in order to establish a robust and reliable dimensional set of variables that quantifies the positive and negative valence, cognition and arousal domains, including interoception, to generate clinically useful treatment predictions. METHODS AND ANALYSIS: The T-1000 is a naturalistic study that will recruit, assess and longitudinally follow 1000 participants, including healthy controls and treatment-seeking individuals with mood, anxiety, substance use and eating disorders. Each participant will undergo interview, behavioural, biomarker and neuroimaging assessments over the course of 1 year. The study goal is to determine how disorders of affect, substance use and eating behaviour organise across different levels of analysis (molecules, genes, cells, neural circuits, physiology, behaviour and self-report) to predict symptom severity, treatment outcome and long-term prognosis. The data will be used to generate computational models based on Bayesian statistics. The final end point of this multilevel latent variable analysis will be standardised assessments that can be developed into clinical tools to help clinicians predict outcomes and select the best intervention for each individual, thereby reducing the burden of mental disorders, and taking psychiatry a step closer towards personalised medicine. ETHICS AND DISSEMINATION: Ethical approval was obtained from Western Institutional Review Board screening protocol #20101611. The dissemination plan includes informing health professionals of results for clinical practice, submitting results to journals for peer-reviewed publication, presenting results at national and international conferences and making the dataset available to researchers and mental health professionals. TRIAL REGISTRATION NUMBER: NCT02450240; Pre-results.
format Online
Article
Text
id pubmed-5786129
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57861292018-01-31 Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample Victor, Teresa A Khalsa, Sahib S Simmons, W Kyle Feinstein, Justin S Savitz, Jonathan Aupperle, Robin L Yeh, Hung-Wen Bodurka, Jerzy Paulus, Martin P BMJ Open Mental Health INTRODUCTION: Although neuroscience has made tremendous progress towards understanding the basic neural circuitry underlying important processes such as attention, memory and emotion, little progress has been made in applying these insights to psychiatric populations to make clinically meaningful treatment predictions. The overall aim of the Tulsa 1000 (T-1000) study is to use the NIMH Research Domain Criteria framework in order to establish a robust and reliable dimensional set of variables that quantifies the positive and negative valence, cognition and arousal domains, including interoception, to generate clinically useful treatment predictions. METHODS AND ANALYSIS: The T-1000 is a naturalistic study that will recruit, assess and longitudinally follow 1000 participants, including healthy controls and treatment-seeking individuals with mood, anxiety, substance use and eating disorders. Each participant will undergo interview, behavioural, biomarker and neuroimaging assessments over the course of 1 year. The study goal is to determine how disorders of affect, substance use and eating behaviour organise across different levels of analysis (molecules, genes, cells, neural circuits, physiology, behaviour and self-report) to predict symptom severity, treatment outcome and long-term prognosis. The data will be used to generate computational models based on Bayesian statistics. The final end point of this multilevel latent variable analysis will be standardised assessments that can be developed into clinical tools to help clinicians predict outcomes and select the best intervention for each individual, thereby reducing the burden of mental disorders, and taking psychiatry a step closer towards personalised medicine. ETHICS AND DISSEMINATION: Ethical approval was obtained from Western Institutional Review Board screening protocol #20101611. The dissemination plan includes informing health professionals of results for clinical practice, submitting results to journals for peer-reviewed publication, presenting results at national and international conferences and making the dataset available to researchers and mental health professionals. TRIAL REGISTRATION NUMBER: NCT02450240; Pre-results. BMJ Publishing Group 2018-01-24 /pmc/articles/PMC5786129/ /pubmed/29371263 http://dx.doi.org/10.1136/bmjopen-2017-016620 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Mental Health
Victor, Teresa A
Khalsa, Sahib S
Simmons, W Kyle
Feinstein, Justin S
Savitz, Jonathan
Aupperle, Robin L
Yeh, Hung-Wen
Bodurka, Jerzy
Paulus, Martin P
Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample
title Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample
title_full Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample
title_fullStr Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample
title_full_unstemmed Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample
title_short Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample
title_sort tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786129/
https://www.ncbi.nlm.nih.gov/pubmed/29371263
http://dx.doi.org/10.1136/bmjopen-2017-016620
work_keys_str_mv AT victorteresaa tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample
AT khalsasahibs tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample
AT simmonswkyle tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample
AT feinsteinjustins tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample
AT savitzjonathan tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample
AT aupperlerobinl tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample
AT yehhungwen tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample
AT bodurkajerzy tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample
AT paulusmartinp tulsa1000anaturalisticstudyprotocolformultilevelassessmentandoutcomepredictioninalargepsychiatricsample